The impact of biological equivalence examination on physician’s decision to prescribe one drug over others within a therapeutic drug class

• In: Community Pharmacy Section - Poster Session
• At: Salvadore (Brazil) (2006)
• Type: Poster
• Poster code: CPS-P-018
• By: YOO, Bong (College of Pharmacy, Yeungnam University, Kyungsan, South-Korea)
• Co-author(s): Hong, Myung-Ja (Graduate School of Clinical Pharmacy, YU, DAEGU, South-Korea)
  Jang, Mal-Sook (Graduate School of Clinical Pharmacy, YU, DAEGU, South-Korea)
  Shanmugam, Srinivasan (College of Pharmacy, Yeungnam University, KYUNGSAN, South-Korea)
  Cho, Jeong-Min (College of Pharmacy, Yeungnam University, KYUNGSAN, South-Korea)
  Rhee, Jong (College of Pharmacy, Yeungnam University, KYUNGSAN, South-Korea)
  Yoo, Bong (College of Pharmacy, Yeungnam University, KYUNGSAN, South-Korea)
  
• Abstract:

  Korea Food and Drug Administration (KFDA) has been expediting the biological equivalence examination project to encourage generic substitution without expense of inappropriate therapeutic outcomes since 2001. One of the backgrounds for this movement is because the financial situation of the National Health Insurance Corporation (NHIC) of Korea has ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login